Literature DB >> 35874903

Assessing Suitability of a Colorectal Cancer Screening Program in Oman.

Mohammed Fayyadh Bondre1, Murtadha Al Qubtan1, Salim O Al Harthy2.   

Abstract

Colorectal cancer is among the most common cancers globally and carries a high mortality rate. The incidence of colorectal cancer has been increasing in the Middle East, including in Oman. While many countries have implemented a bowel cancer screening program, Oman has yet to establish one. A standard tool for bowel cancer screening is a fecal immunochemical test where a fecal sample is sent to a laboratory to check for blood content in the feces. In Oman, such fecal test kits are available at the primary health care level, but primary care physicians were unaware of the signs and symptoms or screening methods for colorectal cancer. This review article aims to assess the suitability of a colorectal cancer screening program in Oman using guidelines from the Supporting the Use of Research Evidence (SURE) collaboration.
Copyright © 2022, Bondre et al.

Entities:  

Keywords:  bowel cancer screening; colon cancer prevention; colorectal cancer; fecal occult blood test; oman; screening programme

Year:  2022        PMID: 35874903      PMCID: PMC9298662          DOI: 10.7759/cureus.27011

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  15 in total

1.  Medicare Spending for Breast, Prostate, Lung, and Colorectal Cancer Patients in the Year of Diagnosis and Year of Death.

Authors:  Christopher T Chen; Ling Li; Gabriel Brooks; Michael Hassett; Deborah Schrag
Journal:  Health Serv Res       Date:  2017-07-26       Impact factor: 3.402

2.  Colorectal Cancer Patient Characteristics, Treatment and Survival in Oman--a Single Center Study.

Authors:  Shiyam Kumar; Ikram A Burney; Khawaja Farhan Zahid; Philomena Charlotte D Souza; Muna A L Belushi; Taha Dawood Mufti; Waeil A L Meki; Muhammad Furrukh; Mansour S A L Moundhri
Journal:  Asian Pac J Cancer Prev       Date:  2015

3.  Global patterns and trends in colorectal cancer incidence and mortality.

Authors:  Melina Arnold; Mónica S Sierra; Mathieu Laversanne; Isabelle Soerjomataram; Ahmedin Jemal; Freddie Bray
Journal:  Gut       Date:  2016-01-27       Impact factor: 23.059

4.  A Comparison of Fecal Immunochemical and High-Sensitivity Guaiac Tests for Colorectal Cancer Screening.

Authors:  Jean A Shapiro; Janet K Bobo; Timothy R Church; Douglas K Rex; Gary Chovnick; Trevor D Thompson; Ann G Zauber; David Lieberman; Theodore R Levin; Djenaba A Joseph; Marion R Nadel
Journal:  Am J Gastroenterol       Date:  2017-10-10       Impact factor: 10.864

5.  Knowledge, attitude, and perceived barriers regarding colorectal cancer screening practices and risk factors among medical students in Saudi Arabia.

Authors:  Asma Althobaiti; Hoda Jradi
Journal:  BMC Med Educ       Date:  2019-11-14       Impact factor: 3.263

6.  Colorectal cancer awareness and its predictors among adults aged 50-74 years attending primary healthcare in the State of Qatar: a cross-sectional study.

Authors:  Ayman Al-Dahshan; Mohamad Chehab; Mohamed Bala; Mieaad Omer; Omayma AlMohamed; Noora Al-Kubaisi; Nagah Selim
Journal:  BMJ Open       Date:  2020-07-07       Impact factor: 2.692

7.  Cancer Incidence in Oman (1996-2015).

Authors:  Jawad A Al-Lawati; Ibrahim Al-Zakwani; Ibtihal Fadhil; Bassim J Al-Bahrani
Journal:  Oman Med J       Date:  2019-07

8.  The global, regional, and national burden of colorectal cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.

Authors: 
Journal:  Lancet Gastroenterol Hepatol       Date:  2019-10-21

Review 9.  Global colorectal cancer burden in 2020 and projections to 2040.

Authors:  Yue Xi; Pengfei Xu
Journal:  Transl Oncol       Date:  2021-07-06       Impact factor: 4.243

10.  Attitudes toward and Knowledge of Colorectal Cancer Screening among an Omani Adult Population Attending a Teaching Hospital.

Authors:  Mohammed Al-Azri; Sharouq Al-Khatri; Sathiya Murthi Panchatcharam
Journal:  Asian Pac J Cancer Prev       Date:  2020-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.